Kotha Subbaramaiah Selected Research

Kotha Subbaramaiah Research Topics

Disease

38	Neoplasms (Cancer) 01/2017 - 01/2002
23	Carcinogenesis 06/2014 - 08/2002
20	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2002
19	Inflammation (Inflammations) 01/2022 - 07/2006
12	Obesity 01/2022 - 03/2011
6	Oral Leukoplakia 04/2012 - 08/2002
5	Squamous Cell Carcinoma of Head and Neck 11/2009 - 08/2002
4	Li-Fraumeni Syndrome 01/2020 - 03/2014
4	Colonic Neoplasms (Colon Cancer) 04/2015 - 07/2007
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 03/2004
3	Pain (Aches) 01/2019 - 10/2003
3	Colitis 11/2015 - 12/2007
2	Hypertrophy 04/2017 - 04/2013
2	Weight Loss (Weight Reduction) 08/2015 - 11/2013
2	Adenoma (Adenomas) 12/2012 - 08/2008
2	Overweight 04/2012 - 07/2011
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2012 - 04/2007
2	Lung Neoplasms (Lung Cancer) 03/2010 - 09/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2008 - 06/2005
1	Hypoxia (Hypoxemia) 01/2019
1	Insulin Resistance 01/2017
1	Weight Gain 08/2015
1	Squamous Intraepithelial Lesions 01/2012
1	Coinfection 01/2012
1	Infections 01/2012
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2012
1	Skin Neoplasms (Skin Cancer) 09/2010
1	Disease Progression 11/2009
1	Pneumonia (Pneumonitis) 04/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2009

Drug/Important Bio-Agent (IBA)

23	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2011 - 05/2002
18	Aromatase (CYP19)IBA 01/2022 - 05/2006
15	Hormones (Hormone)IBA 01/2019 - 05/2004
13	ProstaglandinsIBA 01/2019 - 08/2002
11	Dinoprostone (PGE2)FDA Link 01/2019 - 10/2002
11	Estrogens (Estrogen)FDA Link 04/2017 - 05/2004
10	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 11/2009 - 08/2002
9	EnzymesIBA 04/2017 - 08/2002
9	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2013 - 01/2002
9	Prostaglandins EIBA 04/2012 - 08/2003
8	Proteins (Proteins, Gene)FDA Link 06/2014 - 05/2002
8	SmokeIBA 03/2010 - 01/2005
6	Prostaglandin-E SynthasesIBA 01/2020 - 08/2003
6	Celecoxib (Celebrex)FDA Link 08/2008 - 10/2002
5	Biomarkers (Surrogate Marker)IBA 11/2013 - 03/2011
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 07/2006
4	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 06/2014 - 07/2008
4	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 06/2014 - 11/2008
4	7- hydroxy- 5,11- dioxotetranorprostane- 1,16- dioic acidIBA 01/2012 - 08/2005
4	Messenger RNA (mRNA)IBA 01/2012 - 08/2003
4	15-hydroxyprostaglandin dehydrogenaseIBA 09/2010 - 02/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015 - 02/2006
3	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 06/2014 - 11/2008
3	Fatty Acids (Saturated Fatty Acids)IBA 11/2013 - 03/2011
3	human ERBB2 proteinIBA 10/2013 - 10/2002
3	ErbB Receptors (EGF Receptor)IBA 10/2007 - 01/2005
2	LeptinIBA 04/2017 - 01/2017
2	C-Reactive ProteinIBA 04/2017 - 01/2017
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2014 - 11/2008
2	Benzo(a)pyreneIBA 06/2014 - 04/2012
2	LigandsIBA 06/2014 - 04/2012
2	Pharmaceutical PreparationsIBA 11/2013 - 10/2013
2	Toll-Like Receptor 4IBA 11/2013 - 12/2007
2	Progesterone Receptors (Progesterone Receptor)IBA 04/2013 - 04/2012
2	AzoxymethaneIBA 12/2012 - 12/2007
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2009 - 05/2004
2	Protein Isoforms (Isoforms)IBA 08/2008 - 04/2004
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2007 - 01/2005
1	Sirtuin 1IBA 01/2019
1	Pioglitazone (Actos)FDA Link 01/2018
1	AdiponectinIBA 01/2018
1	Insulin (Novolin)FDA Link 04/2017
1	Triglycerides (Triacylglycerol)IBA 04/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 11/2015
1	CP 31398IBA 03/2014
1	Adenosine Triphosphatases (ATPase)IBA 03/2014
1	ZyflamendIBA 09/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2013
1	Sarcosine (Methylglycine)IBA 12/2012
1	alpha-hydroxyglutarateIBA 12/2012
1	Biological ProductsIBA 04/2012
1	Cyclic AMP (AMP, Cyclic)IBA 04/2012
1	Immunoglobulin G (IgG)IBA 05/2011
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 05/2011
1	Aromatase InhibitorsIBA 03/2011
1	Indicators and Reagents (Reagents)IBA 05/2010
1	Contrast MediaIBA 05/2010
1	CreatinineIBA 11/2009
1	6-formylindolo(3,2-b)carbazoleIBA 10/2009
1	Bile Acids and Salts (Bile Acids)IBA 09/2009
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 04/2009

Therapy/Procedure

4	Chemoprevention 03/2010 - 01/2005
3	Therapeutics 04/2015 - 06/2005
2	Caloric Restriction 01/2022 - 04/2013
2	Mastectomy (Mammectomy) 04/2017 - 01/2017
2	Aftercare (After-Treatment) 10/2007 - 01/2005
2	Drug Therapy (Chemotherapy) 06/2005 - 08/2002
1	Analgesia 10/2013